CLP Newsletter Fall 2019

Dissolvable Optical Sensor Moves Medicine Forward

Dissolvable Optical Sensor Moves Medicine Forward

Treating severe brain injury often requires immediate surgery, including implantation of an electronic sensor that monitors tissues and fluids and digitally provides real-time information about intracranial pressure, temperature and wound healing.  These devices,...

Building Better Biologics: A Q&A with Danielle Tullman-Ercek

Building Better Biologics: A Q&A with Danielle Tullman-Ercek

Building Better Biologics: A Q&A with Danielle Tullman-Ercek Like a master Lego® builder who constructs elaborate figures using tiny interlocking blocks, Chemistry of Life Processes Institute member Danielle Tullman-Ercek manipulates parts of bacteria and viruses...

Former CLP Trainee Brings Collaborative Mindset to AbbVie

Former CLP Trainee Brings Collaborative Mindset to AbbVie

Before becoming a trainee in the Chemistry of Life Processes NIH Graduate Training Program at Northwestern, Ryan McClure was already performing research at the interface of chemistry and biology. A joint student between the labs of Regan Thomson...

CLP Research Tools, Expertise Continue To Grow

CLP Research Tools, Expertise Continue To Grow

Watching neurons die provides Richard Morimoto with clues on how he might better keep them alive. The molecular biologist specifically studies neurons exposed to cell stress as well as those expressing proteins linked to neurodegenerative diseases.Now, a new...

Three Distinguished Researchers Join CLP’s Faculty Executive Committee

Three Distinguished Researchers Join CLP’s Faculty Executive Committee

Chemistry of Life Processes Institute recently welcomed Northwestern faculty members Amy Rosenzweig, Danielle Tullman-Ercek, and Monica Olvera de la Cruz to its Faculty Executive Committee. All three distinguished researchers are members of the Institute. The...

‘Trojan horse’ anticancer drug disguises itself as fat

‘Trojan horse’ anticancer drug disguises itself as fat

For years, drug developers have tried, but failed, to build the perfect biological Trojan horse. Now, a new approach that disguises chemotherapeutic drugs as fat stands to outsmart, penetrate and destroy tumors. For the first time, a team of Northwestern researchers,...

CLP Research Centers and Core Updates